<DOC>
	<DOCNO>NCT01532284</DOCNO>
	<brief_summary>A pragmatic , multicentre , randomize double-blind control trial intention-to-treat analysis , use preimplantation genetic screening ( PGS ) aneuploidy mean microarray comparative genomic hybridization ( CGH ) chromosomal analysis polar body ( PB ) oocytes collected ovarian stimulation vitro fertilization ( IVF ) , intention assess genetic competence oocyte advance biological age , effect technique reproductive outcome .</brief_summary>
	<brief_title>The Eshre Study Into The Evaluation Oocyte Euploidy Microarray Analysis</brief_title>
	<detailed_description />
	<mesh_term>Aneuploidy</mesh_term>
	<criteria>infertility indication IVF ICSI ; patient 36th 41st birthday ( time sign ICF i.e . max 40years 364days day signing informed consent ) ; BMI range 18 30 kg per m2 ; patient prepare accept transfer two embryo ; absence type genetic abnormality patient 's personal family history ; normal karyotype ( optional ) treatment involve donor oocyte ( donor sperm allow subject local practice regulation provide karyotype sperm donor available normal ) ; menstrual irregularity ( &lt; 24 &gt; 35 day ) ; three previous fail IVF ICSI cycle , present partner . ( Definition fail cycle : 'absence clinical pregnancy relate treatment embryo transfer result oocyte retrieval current intended pregnancy current partner ; transfer include transfer fresh frozen within treatment ; clinical pregnancy define presence gestational sac early ultrasound include early clinical miscarriage , late miscarriage clinically confirm extrauterine pregnancy , exclude preclinical miscarriage ( biochemical pregnancy ) ; three clinical miscarriage ; poor response previous cycle ; low ovarian reserve ( At least one follow two feature must present : ( 1 ) previous poor ovarian response ( â‰¤ 3 oocyte conventional stimulation 119 protocol ) ; ( 2 ) abnormal ovarian reserve test ( i.e . AFC &lt; 5 follicle AMH &lt; 0,5 ng/mL ) * ( adapt Ferraretti et al. , 2011 ) ; cycle require surgical sperm recovery procedure ; total asthenozoospermia and/or globozoospermia . type genetic abnormality family history genetic abnormality subject partner</criteria>
	<gender>Female</gender>
	<minimum_age>36 Years</minimum_age>
	<maximum_age>41 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>aneuploid oocyte</keyword>
	<keyword>ICSI</keyword>
	<keyword>IVF</keyword>
	<keyword>Polar Body Biopsy</keyword>
</DOC>